HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Kodiak Sciences Inc. operates as a clinical stage biopharmaceutical company. The Company specializes in novel therapeutics to treat chronic and high-prevalence retinal diseases. Kodiak Sciences serves customers in the Unites States.
Market Cap | 5.78 Billion | Shares Outstanding | 44.803 Million | Avg 30-day Volume | 322.855 Thousand | ||
P/E Ratio | Dividend Yield | EPS | |||||
Price/Sales | Debt to Equity | EBITDA | |||||
Price to Book Value | 0.0 | Forward PE | -29.0 | Enterprise Value | |||
Total Cash | Current Debt | Gross Profit | |||||
BETA | 1.16467 | 52-week High/Low | 171.21 / 35.49 | Price to Cash FLow (P/CF) | -9999999.0 | ||
Data provided by IEX Cloud |
Q4 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 3 | 3 | 0.0% | 2 (0.12%) | 2 (0.12%) | 0.0% |
Funds Holding: | 169 | 137 | 23.36% | 47 (2.83%) | 42 (2.62%) | 11.9% |
13F shares: | 43.462 Million | 36.867 Million | 17.89% | 25.277 Million | 22.195 Million | 13.88% |
% Ownership | 85.5968 | 82.2856 | 4.02% | 49.7818 | 49.5392 | 0.49% |
New Positions: | 52 | 28 | 85.71% | 14 | 9 | 55.56% |
Increased Positions | 56 | 46 | 21.74% | 11 | 17 | -35.29% |
Closed Positions | 20 | 16 | 25.0% | 10 | 7 | 42.86% |
Reduced Positions | 47 | 44 | 6.82% | 19 | 12 | 58.33% |
Total Calls | 347.539 Thousand | 71.552 Thousand | 385.72% | 86.9 Thousand | 13.1 Thousand | 563.36% |
Total Puts | 82.613 Thousand | 355.098 Thousand | -76.74% | 35.8 Thousand | 273.885 Thousand | -86.93% |
PUT/CALL Ratio | 0.24 | 4.96 | -95.16% | 0.41 | 20.91 | -98.04% |
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
33.9 Thousand total shares from 14 transactions
33.9 Thousand total shares from 2 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
EHRLICH JASON SEE REMARKS |
|
340,668 | 2021-02-22 | 19 |
PERLROTH VICTOR CHAIRMAN, PRESIDENT AND CEO |
|
3,508,038 | 2020-12-31 | 2 |
|
13,879,952 | 2020-11-20 | 8 | |
|
0 | 2020-06-30 | 2 | |
|
0 | 2020-06-30 | 2 | |
|
0 | 2020-06-30 | 3 | |
BORGESON JOHN A. SEE REMARKS |
|
0 | 2020-06-30 | 1 |
|
0 | 2020-06-30 | 1 | |
|
0 | 2020-06-30 | 3 | |
LIANG HONG SVP, DISCOVERY MEDICINE |
|
130,166 | 2020-04-02 | 3 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-02-24 16:44:26 -0500 | 2021-02-22 | M | 6,950 | d | 290,325 | direct | ||||||||||
2021-02-24 16:44:26 -0500 | 2021-02-22 | S | 1,611 | $125.97 | d | 52,583 | direct | yes | ||||||||
2021-02-24 16:44:26 -0500 | 2021-02-22 | S | 262 | $122.00 | d | 57,031 | direct | yes | ||||||||
2021-02-24 16:44:26 -0500 | 2021-02-22 | S | 413 | $129.18 | d | 50,343 | direct | yes | ||||||||
2021-02-24 16:44:26 -0500 | 2021-02-22 | S | 2,150 | $124.92 | d | 54,194 | direct | yes | ||||||||
2021-02-24 16:44:26 -0500 | 2021-02-22 | M | 6,950 | $10.29 | a | 57,293 | direct | |||||||||
2021-02-24 16:44:26 -0500 | 2021-02-22 | S | 1,827 | $127.34 | d | 50,756 | direct | yes | ||||||||
2021-02-24 16:44:26 -0500 | 2021-02-22 | S | 687 | $123.56 | d | 56,344 | direct | yes | ||||||||
2021-01-22 17:22:38 -0500 | 2021-01-20 | M | 26,950 | $10.29 | a | 77,293 | direct | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | |||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 1,335 | $167.20 | d | 50,343 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | ||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 1,497 | $164.51 | d | 57,907 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | ||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 4,204 | $161.03 | d | 66,421 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | ||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 3,097 | $166.51 | d | 51,678 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | ||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 2,061 | $163.10 | d | 59,404 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | ||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 6,668 | $159.96 | d | 70,625 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | ||
2021-01-22 17:22:38 -0500 | 2021-01-20 | M | 26,950 | d | 297,275 | direct | ||||||||||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 3,132 | $165.64 | d | 64,775 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 | ||
2021-01-22 17:22:38 -0500 | 2021-01-20 | S | 4,956 | $162.06 | d | 61,465 | direct | yes | -6.402 | -15.8958 | 0.0 | 1 | -18.9749 | 5 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
KODIAK SCIENCES INC KOD | 2021-03-02 13:15:02 UTC | -0.2306 | 0.3006 | 70000 |
KODIAK SCIENCES INC KOD | 2021-03-02 12:45:03 UTC | -0.2306 | 0.3006 | 70000 |
KODIAK SCIENCES INC KOD | 2021-03-01 22:15:04 UTC | -0.2306 | 0.3006 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 21:45:03 UTC | -0.2306 | 0.3006 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 21:15:03 UTC | -0.2306 | 0.3006 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 20:45:02 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 20:15:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 19:45:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 19:15:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 18:45:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 18:15:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 17:45:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 17:15:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 16:45:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 16:15:02 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 15:45:03 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 15:15:02 UTC | -0.2093 | 0.2793 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 14:45:03 UTC | -0.1879 | 0.2579 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 14:15:03 UTC | -0.1879 | 0.2579 | 65000 |
KODIAK SCIENCES INC KOD | 2021-03-01 13:45:03 UTC | -0.1879 | 0.2579 | 65000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund | KOD | -811.0 shares, $-73646.91 | 2020-10-31 | N-PORT |
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund | KOD | -115.0 shares, $-16894.65 | 2020-12-31 | N-PORT |
FundVantage Trust- Gotham Hedged Plus Fund | KOD | -314.0 shares, $-46129.74 | 2020-12-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | KOD | -1.0 shares, $-47.7 | 2020-03-31 | N-PORT |